A complete application in a minute
Tailored resume and cover letter, ready to send.
Exelixis Inc. is seeking a Senior Financial Analyst - BD and M&A to drive financial analysis supporting executive decisions and corporate development initiatives in biotech.
You'll build valuation models, perform DCFs, and advise on licensing and potential acquisitions, while collaborating with cross‑functional teams to shape strategic options and optimize capital decisions.
The Senior Financial Analyst - BD and M&A will be responsible for the execution of financial analysis to support the executive leadership team on critical business decisions. This role will perform duties to support corporate development, business development, strategic planning, life cycle management and general corporate finance activities.
Corporate and Business Development
Lifecyle Management and Strategic Planning
Build and maintain effective relationships with cross-functional stakeholders to support collaboration, alignment, and successful execution of business priorities
Corporate Finance
SUPERVISORY RESPONSIBILITIES
No supervisory responsibilities
Education
Experience
Knowledge, Skills and Abilities Required
Travel Requirements
0% This position does not require travel.
#LI-HG1
Our compensation reflects the cost of labor across severalU.S. geographic markets, and we pay differently based on those defined markets.
The base pay range for this positionis $116,000 - $166,000 annually.
The base pay range may take into account the candidate’s geographic region, which will adjust the pay depending on the specific work location.
The base pay offered will take into account the candidate’s geographic region, job-related knowledge, skills, experience and internal equity, among other factors.
In addition to the base salary, as part of our Total Rewards program, Exelixis offers comprehensive employee benefits package, including a 401k plan with generous company contributions, group medical, dental and vision coverage, life and disability insurance, and flexible spending accounts.
Employees are also eligible for a discretionary annual bonus program, or if field sales staff, a sales-based incentive plan.
Exelixis also offers employees the opportunity to purchase company stock, and receive long-term incentives, 15 accrued vacation days in their first year, 17 paid holidays including a company-wide winter shutdown in December, and up to 10 sick days throughout the calendar year.
If you have a disability and need an accommodation in relation to the recruiting process, please email us at: ApplicantAccommodations@exelixis.com.
WORKING CONDITIONS: Our office is a modern space that fosters collaboration and creativity. Teams work closely together, sharing ideas and solutions in a supportive atmosphere. We provide all necessary equipment, including dual monitors and ergonomic chairs, to ensure a comfortable workspace.
DISCLAIMER: The preceding job description has been designed to indicate the general nature and level of work performed by employees within this classification. It is not designed to contain or be interpreted as a comprehensive inventory of all duties, responsibilities and qualifications required of employees assigned to the job.
We are an Equal Opportunity Employer and do not discriminate against any employee or applicant for employment because of race, color, sex, age, national origin, religion, sexual orientation, gender identity, status as a veteran, and basis of disability or any other federal, state or local protected class.
Every Exelixis employee is united in an ambitious cause: to launch innovative medicines that give patients and their families hope for the future. In this pursuit, we know our employees are our most valuable asset.
After operating in the challenging biotech sector for 25 years, we have a proven track record of resiliency in the face of adversity. The success of our lead product has provided a solid commercial foundation allowing us to reinvigorate our research efforts, and grow our team in areas such as Drug Discovery, Clinical Development and Commercial.
As we expand our global partnerships and further reinvest in R&D to help us discover the next breakthrough for difficult-to-treat cancers, we’re seeking to add talented, dedicated employees to power our mission. Cancer is our cause. Make it yours, too.